[TEVA] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -3,206.43%
YoY- -1,285.03%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 3,910,000 3,982,000 4,452,000 3,978,000 3,870,000 4,357,000 4,468,000 -8.51%
PBT 308,000 144,000 137,000 -4,459,000 -51,000 -33,000 -38,000 -
Tax 98,000 62,000 -21,000 16,000 -104,000 -59,000 -119,000 -
NP 207,000 77,000 150,000 -4,349,000 140,000 69,000 109,000 53.41%
Tax Rate -31.82% -43.06% 15.33% - - - - -
Total Cost 3,703,000 3,905,000 4,302,000 8,327,000 3,730,000 4,288,000 4,359,000 -10.31%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 5.29 1.93 3.37 -109.33 3.62 1.58 2.44 67.59%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS 0.19 0.07 0.14 -3.97 0.13 0.06 0.10 53.46%
EPS Diluted 0.19 0.07 0.14 -3.97 0.13 0.06 0.10 53.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.